John Magenau

7.3k total citations
77 papers, 1.8k citations indexed

About

John Magenau is a scholar working on Hematology, Immunology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, John Magenau has authored 77 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Hematology, 18 papers in Immunology and 16 papers in Public Health, Environmental and Occupational Health. Recurrent topics in John Magenau's work include Hematopoietic Stem Cell Transplantation (43 papers), Acute Myeloid Leukemia Research (22 papers) and Acute Lymphoblastic Leukemia research (15 papers). John Magenau is often cited by papers focused on Hematopoietic Stem Cell Transplantation (43 papers), Acute Myeloid Leukemia Research (22 papers) and Acute Lymphoblastic Leukemia research (15 papers). John Magenau collaborates with scholars based in United States, Japan and United Kingdom. John Magenau's co-authors include Pavan Reddy, Thomas Braun, James E. Martin, John E. Levine, Sung Won Choi, Peter J. Carnevale, Melvin J. Kimmel, Tomomi Toubai, Attaphol Pawarode and James L.M. Ferrara and has published in prestigious journals such as Journal of Personality and Social Psychology, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

John Magenau

70 papers receiving 1.7k citations

Peers

John Magenau

HEMAT

IMMUN

ONCOL

SPS

David Williamson United States

Hans Pruijt Netherlands

Francisco J. Medina Spain

Stephanie Williams United States

David Nelken Israel

James A. Wolff United States

Eamonn Molloy Ireland

Neil Abramson United States

David Emanuel United States

Denise Williams United States

David Williamson United States

John Magenau

327 ×0.3

HEMAT

634 ×1.1

IMMUN

519 ×1.7

ONCOL

149 ×0.6

SPS

301 ×1.7

Citations per year, relative to John Magenau John Magenau (= 1×) peers David Williamson

Countries citing papers authored by John Magenau

Since Specialization

Citations

This map shows the geographic impact of John Magenau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Magenau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Magenau more than expected).

Fields of papers citing papers by John Magenau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Magenau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Magenau. The network helps show where John Magenau may publish in the future.

Co-authorship network of co-authors of John Magenau

This figure shows the co-authorship network connecting the top 25 collaborators of John Magenau. A scholar is included among the top collaborators of John Magenau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Magenau. John Magenau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Frame, David, Sarah Anand, Sung Won Choi, et al.. (2024). Comparing 2-day vs 3-day flu-CY lymphodepleting regimens for CD19 CAR T-cell therapy in patients with non-hodgkin’s lymphoma. Frontiers in Immunology. 15. 1403145–1403145. 5 indexed citations

Riwes, Mary, Jonathan L. Golob, John Magenau, et al.. (2023). Rational Modification of Human Gut Microbiome and Metabolites By Dietary Resistant Starch in Allogeneic Hematopoietic Stem Cell Transplantation: A Feasibility Study. Blood. 142(Supplement 1). 2190–2190. 1 indexed citations

O’Donnell, Paul V., Claudio G. Brunstein, Ephraim J. Fuchs, et al.. (2021). Umbilical Cord Blood or HLA-Haploidentical Transplantation: Real-World Outcomes versus Randomized Trial Outcomes. Transplantation and Cellular Therapy. 28(2). 109.e1–109.e8. 10 indexed citations

Torii, Yuka, Tomomi Toubai, Masashi Hosokawa, et al.. (2021). A unique three-way Philadelphia chromosome variant t(4;9;22)(q21;q34;q11.2) in a newly diagnosed patient with chronic phase chronic myeloid leukemia: a case report and review of the literature. Journal of Medical Case Reports. 15(1). 285–285. 4 indexed citations

Fuchs, Ephraim J., Paul V. O’Donnell, Mary Eapen, et al.. (2020). Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial. Blood. 137(3). 420–428. 106 indexed citations

D’Souza, Anita, Parameswaran Hari, Marcelo C. Pasquini, et al.. (2019). A Phase 2 Study of Pembrolizumab during Lymphodepletion after Autologous Hematopoietic Cell Transplantation for Multiple Myeloma. Biology of Blood and Marrow Transplantation. 25(8). 1492–1497. 24 indexed citations

Magenau, John, Steven C. Goldstein, Robert J. Soiffer, et al.. (2018). α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease. Blood. 131(12). 1372–1379. 83 indexed citations

Fauer, Alex, Flora Hoodin, Lyndsey Runaas, et al.. (2018). Impact of a health information technology tool addressing information needs of caregivers of adult and pediatric hematopoietic stem cell transplantation patients. Supportive Care in Cancer. 27(6). 2103–2112. 24 indexed citations

Pawarode, Attaphol, Anita D’Souza, Marcelo C. Pasquini, et al.. (2017). Phase 2 Study of Pembrolizumab during Lymphodepleted State after Autologous Hematopoietic Cell Transplantation in Multiple Myeloma Patients. Blood. 130. 339–339. 6 indexed citations

10.

Saliba, Rima M., Stefanie Sarantopoulos, Carrie L. Kitko, et al.. (2017). B-cell activating factor (BAFF) plasma level at the time of chronic GvHD diagnosis is a potential predictor of non-relapse mortality. Bone Marrow Transplantation. 52(7). 1010–1015. 20 indexed citations

11.

Toubai, Tomomi, Corinne Rossi, Katherine Oravecz-Wilson, et al.. (2017). Siglec-G represses DAMP-mediated effects on T cells. JCI Insight. 2(14). 39 indexed citations

12.

Toubai, Tomomi, Nathan D. Mathewson, John Magenau, & Pavan Reddy. (2016). Danger Signals and Graft-versus-host Disease: Current Understanding and Future Perspectives. Frontiers in Immunology. 7. 539–539. 68 indexed citations

13.

Kitko, Carrie L., Thomas Braun, Daniel R. Couriel, et al.. (2015). Combination Therapy for Graft-versus-Host Disease Prophylaxis with Etanercept and Extracorporeal Photopheresis: Results of a Phase II Clinical Trial. Biology of Blood and Marrow Transplantation. 22(5). 862–868. 29 indexed citations

14.

Pawarode, Attaphol, Shin Mineishi, Pavan Reddy, et al.. (2015). Reducing Treatment-Related Mortality Did Not Improve Outcomes of Allogeneic Myeloablative Hematopoietic Cell Transplantation for High-Risk Multiple Myeloma: A University of Michigan Prospective Series. Biology of Blood and Marrow Transplantation. 22(1). 54–60. 10 indexed citations

15.

Gatza, Erin, Thomas Braun, John E. Levine, et al.. (2014). Etanercept plus Topical Corticosteroids as Initial Therapy for Grade One Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 20(9). 1426–1434. 16 indexed citations

16.

Levine, John E., Thomas Braun, Andrew C. Harris, et al.. (2014). A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study. The Lancet Haematology. 2(1). e21–e29. 179 indexed citations

17.

Magenau, John & Pavan Reddy. (2014). Next generation treatment of acute graft-versus-host disease. Leukemia. 28(12). 2283–2291. 20 indexed citations

18.

Harris, Andrew C., Carrie L. Kitko, Daniel R. Couriel, et al.. (2012). Extramedullary relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomes. Haematologica. 98(2). 179–184. 71 indexed citations

19.

Magenau, John & Scott M. Schuetze. (2008). New targets for therapy of sarcoma. Current Opinion in Oncology. 20(4). 400–406. 15 indexed citations

20.

Magenau, John. (1981). A laboratory investigation of alternative dispute resolution procedures in bargaining. University Microfilms International eBooks. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact